The board of Cerebral voted to replace co-founder Kyle Robertson, the Wall Street Journal reported May 17. Mr. Robertson later called the move illegal, according to the newspaper.
The U.S. Justice Department is investigating the company, which prescribes ADHD medications like Adderall virtually, over possible violations of the Controlled Substances Act. Cerebral recently paused the prescribing of most controlled substances and changed its online ads after critics said it could be fueling an addiction crisis.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
